Nefopam analgesia and its role in multimodal analgesia: A review of preclinical and clinical studies

Clinical and Experimental Pharmacology and Physiology

Volumn 43, Issue 1, 2016, Pages 3-12

  Girard, Philippe ^a   Chauvin, Marcel ^b   Verleye, Marc ^a  

^a Service de Pharmacologie   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Analgesia; Clinical; Ketoprofen; Morphine; Multimodal; Nefopam; Paracetamol; Preclinical

Indexed keywords

ACETYLSALICYLIC ACID; KETOPROFEN; MORPHINE; NEFOPAM; NIMESULIDE; PARACETAMOL; TENOXICAM; ANALGESIC AGENT; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANALGESIA; ANALGESIC ACTIVITY; ARTICLE; DRUG POTENTIATION; DRUG USE; HUMAN; INFLAMMATORY PAIN; NONHUMAN; PAIN; PAIN INTENSITY; PAIN SEVERITY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); ANIMAL; DRUG INTERACTION; PROCEDURES;

ANALGESIA; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG INTERACTIONS; HUMANS; NEFOPAM;

EID: 84954441440     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12506     Document Type: Article

References (66)

1. Gritsenko K, Khelemsky Y, Kaye AD, Vadivelu N, Urman RD. Multimodal therapy in perioperative analgesia. Best Pract. Res. Clin. Anaesthesiol. 2014; 28: 59-79.
2. Rafiq S, Steinbruchel DA, Wanscher MJ et al. Multimodal analgesia versus traditional opiate based analgesia after cardiac surgery, a randomized controlled trial. J. Cardiothorac. Surg. 2014; 9: 52. doi:10.1186/1749-8090-9-52.
3. Elvir-Lazo OL, White PF. Postoperative pain management after ambulatory surgery: Role of multimodal analgesia. Anesthesiol. Clin. 2010; 28: 217-24.
4. Curry SL, Cogar SM, Cook JL. Nonsteroidal antiinflammatory drugs: A review. J. Am. Anim. Hosp. Assoc. 2005; 41: 298-309.
5. Guignard B, Bossard AE, Coste C et al. Acute opioid tolerance: Intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 2000; 93: 409-17.
6. Guindon J, Walczak JS, Beaulieu P. Recent advances in the pharmacological management of pain. Drugs 2007; 67: 2121-33.
7. Lee WM. Acetaminophen and the U.S. Acute Liver Failure Study Group: Lowering the risks of hepatic failure. Hepatology 2004; 40: 6-9.
8. Kehlet H, Dahl JB. The value of "multimodal" or "balanced analgesia" in postoperative pain treatment. Anesth. Analg. 1993; 77: 1048-56.
9. Beloeil H. Postoperative non-opioid analgesics management. Presse Med. 2015; 44: 601-9.
10. White PF. Multimodal analgesia: Its role in preventing postoperative pain. Curr. Opin. Investig. Drugs 2008; 9: 76-82.
11. Heel RC, Brogden RN, Pakes GE, Speight TM, Avery GS. Nefopam: A review of its pharmacological properties and therapeutic efficacy. Drugs 1980; 19: 249-67.
12. Kim KH, Abdi S. Rediscovery of nefopam for the treatment of neuropathic pain. Korean J. Pain 2014; 27: 103-11.
13. Piercey MF, Schroeder LA. Spinal and Supraspinal sites for morphine and nefopam analgesia in the mouse. Eur. J. Pharmacol. 1981; 74: 135-40.
14. Evans MS, Lysakowski C, Tramer MR. Nefopam for the prevention of postoperative pain: Quantitative systematic review. Br. J. Anaesth. 2008; 101: 610-17.
15. Conway AC, Mitchell CL. Analgesic studies with nefopam hydrochloride. Arch. Int. Pharmacodyn. Ther. 1977; 226: 156-71.
16. Kvam DC. Nefopam hydrochloride: A survey of preclinical pharmacology. Clin. Ther. 1979; 2 (Suppl. B): 1-12.
17. Gasser JC, Bellville JW. Respiratory effects of nefopam. Clin. Pharmacol. Ther. 1975; 18: 175-9.
18. Stainthorp SF, Morton AK, Pleuvry BJ. The effects of nefopam on blood acid-base status in the rabbit: Interactions with morphine in the mouse and rabbit. J. Pharm. Pharmacol. 1980; 32: 689-92.
19. Dordoni PL, Della VM, Stefanelli A et al. Effect of ketorolac, ketoprofen and nefopam on platelet function. Anaesthesia 1994; 49: 1046-9.
20. Girard P, Pansart Y, Coppe MC, Gillardin JM. Nefopam reduces thermal hypersensitivity in acute and postoperative pain models in the rat. Pharmacol. Res. 2001; 44: 541-5.
21. Buritova J, Besson JM. Effects of nefopam on the spinal nociceptive processes: A c-Fos protein study in the rat. Eur. J. Pharmacol. 2002; 441: 67-74.
22. Biella GE, Groppetti A, Novelli A, Fernandez-Sanchez MT, Manfredi B, Sotgiu ML. Neuronal sensitization and its behavioral correlates in a rat model of neuropathy are prevented by a cyclic analog of orphenadrine. J. Neurotrauma 2003; 20: 593-601.
23. Laboureyras E, Chateauraynaud J, Richebe P, Simonnet G. Long-term pain vulnerability after surgery in rats: Prevention by nefopam, an analgesic with antihyperalgesic properties. Anesth. Analg. 2009; 109: 623-31.
24. Hunskaar S, Fasmer OB, Broch OJ, Hole K. Involvement of central serotonergic pathways in nefopam-induced antinociception. Eur. J. Pharmacol. 1987; 138: 77-82.
25. Fuller RW, Snoddy HD. Evaluation of nefopam as a monoamine uptake inhibitor in vivo in mice. Neuropharmacology 1993; 32: 995-9.
26. Fernandez-Sanchez MT, Diaz-Trelles R, Groppetti A et al. Novel effect of nefopam preventing cGMP increase, oxygen radical formation and neuronal death induced by veratridine. Neuropharmacology 2001; 41: 935-42.
27. Verleye M, Andre N, Heulard I, Gillardin JM. Nefopam blocks voltage-sensitive sodium channels and modulates glutamatergic transmission in rodents. Brain Res. 2004; 1013: 249-55.
28. Novelli A, Diaz-Trelles R, Groppetti A, Fernandez-Sanchez MT. Nefopam inhibits calcium influx, cGMP formation, and NMDA receptor-dependent neurotoxicity following activation of voltage sensitive calcium channels. Amino Acids 2005; 28: 183-91.
29. Mimoz O, Incagnoli P, Josse C et al. Analgesic efficacy and safety of nefopam vs. propacetamol following hepatic resection. Anaesthesia 2001; 56: 520-5.
30. Du Manoir B, Aubrun F, Langlois M et al. Randomized prospective study of the analgesic effect of nefopam after orthopaedic surgery. Br. J. Anaesth. 2003; 91: 836-41.
31. Kapfer B, Alfonsi P, Guignard B, Sessler DI, Chauvin M. Nefopam and ketamine comparably enhance postoperative analgesia. Anesth. Analg. 2005; 100: 169-74.
32. Beloeil H, Delage N, Negre I, Mazoit JX, Benhamou D. The median effective dose of nefopam and morphine administered intravenously for postoperative pain after minor surgery: A prospective randomized double-blinded isobolographic study of their analgesic action. Anesth. Analg. 2004; 98: 395-400.
33. Delage N, Maaliki H, Beloeil H, Benhamou D, Mazoit JX. Median effective dose (ED50) of nefopam and ketoprofen in postoperative patients: A study of interaction using sequential analysis and isobolographic analysis. Anesthesiology 2005; 102: 1211-16.
34. Tirault M, Derrode N, Clevenot D, Rolland D, Fletcher D, Debaene B. The effect of nefopam on morphine overconsumption induced by large-dose remifentanil during propofol anesthesia for major abdominal surgery. Anesth. Analg. 2006; 102: 110-17.
35. Richebe P, Picard W, Rivat C et al. Effects of nefopam on early postoperative hyperalgesia after cardiac surgery. J. Cardiothorac. Vasc. Anesth. 2013; 27: 427-35.
36. Remerand F, Le TC, Rosset P et al. Nefopam after total hip arthroplasty: Role in multimodal analgesia. Orthop. Traumatol. Surg. Res. 2013; 99: 169-74.
37. Balandin VV, Gorobets ES. [Postoperative analgesia with nefopam and non-steroidal anti-inflammatory drugs in patients after surgery for tumors of head and neck]. Anesteziol. Reanimatol. 2014; 1: 40-3.
38. Kim K, Kim WJ, Choi DK, Lee YK, Choi IC, Sim JY. The analgesic efficacy and safety of nefopam in patient-controlled analgesia after cardiac surgery: A randomized, double-blind, prospective study. J. Int. Med. Res. 2014; 42: 684-92.
39. Yoo JY, Lim BG, Kim H, Kong MH, Lee IO, Kim NS. The analgesic effect of nefopam combined with low dose remifentanil in patients undergoing middle ear surgery under desflurane anesthesia: A randomized controlled trial. Korean J. Anesthesiol. 2015; 68: 43-9.
40. Aveline C, Gautier JF, Vautier P et al. Postoperative analgesia and early rehabilitation after total knee replacement: A comparison of continuous low-dose intravenous ketamine versus nefopam. Eur. J. Pain 2009; 13: 613-19.
41. Mialon O, Delotte J, Lehert P et al. Comparison between two analgesic protocols on IVF success rates. J. Gynecol. Obstet. Biol. Reprod. (Paris) 2011; 40: 137-43.
42. Eremenko AA, Sorokina LS, Pavlov MV. [Ketoprophen and nefopam combination for postoperative analgesia with minimal use of narcotic analgesics in cardio-surgical patients]. Anesteziol. Reanimatol. 2013; 5: 11-15.
43. Van Elstraete AC, Sitbon P. Median effective dose (ED50) of paracetamol and nefopam for postoperative pain: Isobolographic analysis of their antinociceptive interaction. Minerva Anestesiol. 2013; 79: 232-9.
44. Fletcher D, Mardaye A, Fermanian C, Aegerter P. A national survey of postoperative pain management in France: Influence of type of surgical centres. Ann. Fr. Anesth. Reanim. 2008; 27: 700-8.
45. Fanelli G, Berti M, Baciarello M. Updating postoperative pain management: From multimodal to context-sensitive treatment. Minerva Anestesiol. 2008; 74: 489-500.
46. Girard P, Pansart Y, Gillardin JM. Nefopam potentiates morphine antinociception in allodynia and hyperalgesia in the rat. Pharmacol. Biochem. Behav. 2004; 77: 695-703.
47. Saghaei E, Moini ZT, Sabetkasaei M, Naseri K. Enhancement of antinociception by co-administrations of nefopam, morphine, and nimesulide in a rat model of neuropathic pain. Korean J. Pain 2012; 25: 7-15.
48. Cho SY, Park AR, Yoon MH, Lee HG, Kim WM, Choi JI. Antinociceptive effect of intrathecal nefopam and interaction with morphine in formalin-induced pain of rats. Korean J. Pain 2013; 26: 14-20.
49. Coderre TJ, Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J. Neurosci. 1992; 12: 3665-70.
50. Girard P, Verniers D, Coppe MC, Pansart Y, Gillardin JM. Nefopam and ketoprofen synergy in rodent models of antinociception. Eur. J. Pharmacol. 2008; 584: 263-71.
51. Bennett A, Villa G. Nimesulide: An NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities. Expert Opin. Pharmacother. 2000; 1: 277-86.
52. Girard P, Niedergang B, Pansart Y, Coppe MC, Verleye M. Systematic evaluation of the nefopam-paracetamol combination in rodent models of antinociception. Clin. Exp. Pharmacol. Physiol. 2011; 38: 170-8.
53. Mclintock TTC, Kenny GNC. Assessment of the analgesic efficacy of nefopam hydrochloride after upper abdominal surgery: A study using patient controlled analgesia. Br. J. Surg. 1988; 75: 779-81.
54. Tramoni G, Viale JP, Cazals C, Bhageerutty K. Morphine-sparing effect of nefopam by continuous intravenous injection after abdominal surgery by laparotomy. Eur. J. Anaesthesiol. 2003; 20: 990-2.
55. Sjogren P, Jonsson T, Jensen NH, Drenck NE, Jensen TS. Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain 1993; 55: 93-7.
56. Christensen D, Kayser V. The development of pain-related behaviour and opioid tolerance after neuropathy-inducing surgery and sham surgery. Pain 2000; 88: 231-8.
57. Rivat C, Laulin JP, Corcuff JB, Celerier E, Pain L, Simonnet G. Fentanyl enhancement of carrageenan-induced long-lasting hyperalgesia in rats: Prevention by the N-methyl-D-aspartate receptor antagonist ketamine. Anesthesiology 2002; 96: 381-91.
58. Dahl JB, Rosenberg J, Dirkes WE, Mogensen T, Kehlet H. Prevention of postoperative pain by balanced analgesia. Br. J. Anaesth. 1990; 64: 518-20.
59. Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br. J. Anaesth. 1997; 78: 606-17.
60. Buvanendran A, Kroin JS. Multimodal analgesia for controlling acute postoperative pain. Curr. Opin. Anaesthesiol. 2009; 22: 588-93.
61. Vane JR, Botting RM. New insights into the mode of action of anti-inflammatory drugs. Inflamm. Res. 1995; 44: 1-10.
62. Bejarano PF. Management of inflammatory pain with selective COX-2 inhibitors: Promises and facts. Curr. Rev. Pain 1999; 3: 432-9.
63. Tassorelli C, Greco R, Sandrini G, Nappi G. Central components of the analgesic/antihyperalgesic effect of nimesulide: Studies in animal models of pain and hyperalgesia. Drugs 2003; 63 (Suppl. 1): 9-22.
64. Pini LA, Sandrini M, Vitale G. The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain. Eur. J. Pharmacol. 1996; 308: 31-40.
65. Bonnefont J, Chapuy E, Clottes E, Alloui A, Eschalier A. Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: Effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT. Pain 2005; 114: 482-90.
66. Sandrini M, Pini LA, Vitale G. Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol. Inflamm. Res. 2003; 52: 347-52.